Sleep drug developer Apnimed rises on trading debut — See source for full details.
$APMD
Price history, market instrument context, member research, and related headlines in one place.
APMD key statistics
NasdaqGSUSD
52-week range
$16.1211%$35.29
Latest session $17.25–$18.76Apnimed, Inc. (APMD) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $18.25, up $1.02 (5.89%) from the previous close of $17.23. It has traded between $17.25 and $18.76 in the latest session. Over the past year it has ranged from $16.12 to $35.29, leaving it in the lower quarter of its 52-week range (11%). Reported volume for the session was 260.2K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Apnimed prices upsized IPO at $16 per share, raising $192M — See source for full details.
Apnimed prices IPO at $16 per share, raising $192 million — See source for full details.
Apnimed prices IPO at $16 per share, raising $192 million — See source for full details.
Loading $APMD research…